fluconazole has been researched along with paromomycin in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 6 (54.55) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lombardo, M; Ortalli, M; Quintavalla, A; Rosso, C; Trombini, C; Varani, S | 1 |
Klaus, S; Vardy, D; Zvulunov, A | 1 |
Berman, J | 2 |
Fernandes, AP; Ferreira, LA; Mussi, SV | 1 |
Chacko, A; Feltis, T; Joseph, M; Morris, SK | 1 |
Elmehdi, E; Zerkly, B | 1 |
Francis, JR; Graham, N; Hill, N; Irwin, A; Leung, C; Nourse, C; Wall, N | 1 |
3 review(s) available for fluconazole and paromomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current treatment approaches to leishmaniasis.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine | 2003 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
8 other study(ies) available for fluconazole and paromomycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Evaluation of synthetic substituted 1,2-dioxanes as novel agents against human leishmaniasis.
Topics: Animals; Chlorocebus aethiops; Dioxanes; Drug Design; Humans; Leishmania; Leishmaniasis; Parasitic Sensitivity Tests; Trypanocidal Agents; Vero Cells | 2019 |
Fluconazole for the treatment of cutaneous leishmaniasis.
Topics: Administration, Topical; Animals; Antifungal Agents; Antiprotozoal Agents; Fluconazole; Humans; Leishmania major; Leishmaniasis, Cutaneous; Paromomycin | 2002 |
Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
Topics: Administration, Oral; Administration, Topical; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluconazole; Leishmania major; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Paromomycin; Random Allocation | 2007 |
Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
Topics: Administration, Oral; Administration, Topical; Antiprotozoal Agents; Child, Preschool; Fluconazole; Forehead; Humans; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Paromomycin; Treatment Outcome | 2016 |
[Leg ulcer revealing cutaneous leishmaniasis].
Topics: Administration, Topical; Adolescent; Animals; Antiparasitic Agents; Biopsy; Fluconazole; Humans; Leg Ulcer; Leishmania major; Leishmaniasis, Cutaneous; Male; Paromomycin; Treatment Outcome; Zoonoses | 2017 |
Treatment of Cutaneous Leishmaniasis in a Nonendemic Country: A Case Series of Children in Australia.
Topics: Administration, Topical; Antiprotozoal Agents; Child; Fluconazole; Humans; Leishmaniasis, Cutaneous; Paromomycin | 2022 |